Abeza
Abeza is Abemaciclib, an oral CDK4/6 inhibitor. It is indicated for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer and works by selectively blocking cyclin-dependent kinases 4 and 6 to slow tumor cell proliferation.
Features
| Product Name | Abeza |
| Generic Name | Abemaciclib |
| Formulation | Tablet |
| Available Pack Size | 1X14's,1X14's |
| Available Strength | 150MG,200MG |